Inhaled Nitric Oxide
SKU
MRR-2D668742FD36
Region
Global
Publication Date
February 2024
Delivery
Immediate
2023
USD 778.21 million
2030
USD 1,157.38 million
2024
USD 821.09 million
CAGR
5.83%
Inhaled Nitric Oxide Market by Application (Acute Respiratory Distress Syndrome, Chronic Obstructive Pulmonary Disease, Malaria Treatment), End-Users (Clinic, Hospital) - Global Forecast 2024-2030

[186 Pages Report] The Inhaled Nitric Oxide Market size was estimated at USD 778.21 million in 2023 and expected to reach USD 821.09 million in 2024, at a CAGR 5.83% to reach USD 1,157.38 million by 2030.

Inhaled Nitric Oxide Market
To learn more about this report, request a free sample copy

Inhaled nitric oxide (iNO) is a pulmonary vasodilator used in intensive care medicine to manage acute and chronic pulmonary disorders. It is administered through inhalation, directly reaching the lungs and improving oxygenation by dilating pulmonary blood vessels without significantly affecting blood pressure in other body parts. Its primary use is in neonatal and pediatric populations for conditions including persistent pulmonary hypertension of the newborn (PPHN) and acute respiratory distress syndrome (ARDS). The rising incidence of neonatal conditions requiring iNO therapy, such as PPHN, and an increase in cases of ARDS have significantly propelled the need for inhaled nitric oxide. Additionally, technological advancements enabling portable NO delivery systems have expanded the applicability of the treatments in different care settings, including home care. The ongoing research and potential new indications for iNO in adults with pulmonary diseases offer growth avenues for the market. However, the high cost and stringent regulatory requirements for approval associated with inhaled nitric oxide pose significant barriers to the entry of new players and can limit market growth. Moreover, the exploration of new therapeutic indications and innovations in administration technology that are expected to reduce costs and improve accessibility are promising areas for the inhaled nitric oxide market.

Inhaled Nitric Oxide Market - Global Forecast 2024-2030
To learn more about this report, request a free sample copy
Application: Increasing incidences of chronic obstructive pulmonary disease

Inhaled nitric oxide (iNO) is significant in managing acute respiratory distress syndrome by improving oxygenation and reducing pulmonary arterial pressures. Its vasodilatory effects in ventilated lung regions optimize the matching of ventilation and perfusion, enhancing arterial oxygenation. Chronic obstructive pulmonary disease patients may experience acute exacerbations characterized by worsening of their respiratory symptoms. iNO has been explored as a potential therapy during these exacerbations to improve gas exchange and decrease pulmonary hypertension, which is often associated with COPD. Recent studies have investigated inhaled nitric oxide as an adjunctive treatment for severe malaria. The anti-inflammatory properties of iNO and its ability to improve blood flow and reduce endothelial dysfunction indicate that it is expected to alleviate the vascular complications associated with severe malaria infections. iNO is a well-established therapy for newborns with hypoxic respiratory failure, particularly those with persistent pulmonary hypertension of the newborn (PPHN). iNO improves oxygenation and minimizes the need for extracorporeal membrane oxygenation (ECMO) in affected neonates by selectively dilating the pulmonary vessels. The role of inhaled nitric oxide in tuberculosis (TB) treatment is an emerging area of research, focusing on its potential antibacterial effects, especially against drug-resistant TB strains. iNO's ability to directly kill or inhibit the growth of Mycobacterium tuberculosis in vitro suggests that it is expected to serve as an adjunctive therapy to enhance the efficacy of existing TB treatment regimens.

End-Users: Growing deployment of inhaled nitric oxide devices in hospitals for neonatal and intensive care units

Clinics play an essential role in adopting and applying inhaled nitric oxide therapies. These facilities cater to outpatient services and may not always possess the extensive medical infrastructure found in larger hospitals. Clinics are increasingly incorporating this therapy into their respiratory care offerings with advancements in portable nitric oxide delivery systems. The adoption of inhaled nitric oxide in clinics is pivotal in providing accessible care, particularly in rural or underserved areas, facilitating early intervention and potentially reducing hospital admissions. Hospitals represent the most significant end-users of inhaled nitric oxide, largely owing to their capacity to treat severe and acute conditions requiring intensive care and monitoring. Inhaled nitric oxide is primarily used in neonatal units for babies with persistent pulmonary hypertension of the newborn and in intensive care units for adults suffering from severe acute respiratory distress syndrome (ARDS). Hospitals' adoption and use of inhaled nitric oxide are supported by comprehensive infrastructure, including specialized delivery systems, monitoring equipment, and trained respiratory therapists, to ensure effective and safe administration of the treatment.

Regional Insights

In the Americas, particularly in the United States and Canada, the adoption of inhaled nitric oxide is increasing rapidly owing to the high prevalence of respiratory diseases and the strong presence of healthcare facilities with advanced technological setups. The FDA's proactive role in approving inhaled nitric oxide products for various medical conditions, including pulmonary arterial hypertension and hypoxic respiratory failure, has bolstered the growth of the inhaled nitric oxide market. Moreover, major players in the pharmaceutical and medical device industries in this region are intensively involved in R&D activities, aiming to expand the application range of inhaled nitric oxide therapy. The EMEA region exhibits a dynamic market for inhaled nitric oxide, with Europe majorly contributing to adoption and innovation. The increasing incidence of neonatal conditions and respiratory diseases in this region has heightened the need for effective therapeutic solutions, including inhaled nitric oxide. Regulatory bodies in Europe, such as the European Medicines Agency (EMA), have laid down stringent guidelines and approval processes, ensuring the safety and efficacy of inhaled nitric oxide products. In the Middle East and Africa, the market is gradually expanding, primarily driven by healthcare infrastructure developments and growing awareness about advanced treatment modalities. The APAC region is witnessing the rapid adoption of inhaled nitric oxide therapies owing to rising healthcare expenditure, an increasing population base, and a growing number of preterm birth incidences. Countries such as China, Japan, and India are at the forefront of this adoption, driven by ongoing healthcare reforms, increasing investments in healthcare infrastructure, and rising awareness about innovative therapeutic options, including inhaled nitric oxide. Furthermore, the presence of a significant number of generic pharmaceutical manufacturers in this region offers cost-effective solutions, making inhaled nitric oxide therapy more accessible to a larger patient population.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Inhaled Nitric Oxide Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Inhaled Nitric Oxide Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • Vero Biotech Secures USD 65 Million Credit Facility for Nitric Oxide Delivery System

    Vero Biotech has secured a USD 65 million credit facility earmarked for the enhancement of its innovative nitric oxide delivery system. This strategic financial infusion is poised to revolutionize the administration of inhaled nitric oxide, a critical treatment for patients grappling with respiratory conditions. By leveraging this considerable investment, Vero Biotech aims to further refine its delivery technology, underscoring its commitment to advancing respiratory care and improving patient outcomes. [Published On: 2024-02-07]

  • Third Pole Doses First Patient in Trial with Nitric Oxide Delivery System

    Third Pole Therapeutics has initiated a pioneering early feasibility trial, marking a significant advancement in the treatment of pulmonary hypertension related to interstitial lung disease (PH-ILD) with the first patient being dosed with its innovative portable inhaled nitric oxide (iNO) delivery system, the eNOfit device. This multi-center trial (NCT05867914) aims to assess the safety and tolerability of the eNOfit device, which heralds new possibilities for ambulatory treatment. [Published On: 2023-12-12]

  • Mallinckrodt Announces FDA Clearance of the INOmax EVOLVE DS Delivery System and Approval of the INOmax (Nitric Oxide) Mini-Cylinder

    Mallinckrodt PLC announces the FDA clearance of its cutting-edge INOmax EVOLVE DS delivery system for administering INOmax (nitric oxide gas) for inhalation, marking a significant breakthrough in treating respiratory failure. This system is specifically designed for ventilated patients and ensures a consistent dose of nitric oxide throughout the breathing process by leveraging a unique injector module for precise synchronization and dosage. [Published On: 2023-12-07]

Key Company Profiles

The report delves into recent significant developments in the Inhaled Nitric Oxide Market, highlighting leading vendors and their innovative profiles. These include Air Liquide SA, Beyond Air, Inc., GE HealthCare Technologies, Inc., Getinge AB, Linde PLC, Mallinckrodt PLC, Matheson Tri-Gas, Inc. by Mitsubishi Chemical Group Corporation, Merck KGaA, NIOX Group PLC, Perma Pure LLC by Halma PLC, SOL Group, Third Pole, Inc., and VERO Biotech Inc..

Market Segmentation & Coverage

This research report categorizes the Inhaled Nitric Oxide Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Application
    • Acute Respiratory Distress Syndrome
    • Chronic Obstructive Pulmonary Disease
    • Malaria Treatment
    • Neonatal Respiratory Treatment
    • Tuberculosis Treatment
  • End-Users
    • Clinic
    • Hospital

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Inhaled Nitric Oxide Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Inhaled Nitric Oxide Market?
  3. What are the technology trends and regulatory frameworks in the Inhaled Nitric Oxide Market?
  4. What is the market share of the leading vendors in the Inhaled Nitric Oxide Market?
  5. Which modes and strategic moves are suitable for entering the Inhaled Nitric Oxide Market?

  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & CoverageINHALED NITRIC OXIDE MARKET SEGMENTATION & COVERAGE
    3. Years Considered for the Study
    4. Currency & PricingUNITED STATES DOLLAR EXCHANGE RATE, 2018–2023
    5. Language
    6. Limitations
    7. Assumptions
    8. Stakeholders
  2. Research Methodology
    1. INHALED NITRIC OXIDE MARKET RESEARCH PROCESS
    2. Define: Research Objective
    3. Determine: Research Design
    4. Prepare: Research Instrument
    5. Collect: Data Source
    6. Analyze: Data Interpretation
    7. Formulate: Data Verification
    8. Publish: Research Report
    9. Repeat: Report Update
  3. Executive Summary
    1. INHALED NITRIC OXIDE MARKET SIZE, 2023 VS 2030
  4. Market Overview
    1. IntroductionINHALED NITRIC OXIDE MARKET SIZE, 2018-2030 (USD MILLION)INHALED NITRIC OXIDE MARKET SIZE, 2018-2030 (USD MILLION)
    2. Inhaled Nitric Oxide Market, by RegionINHALED NITRIC OXIDE MARKET SIZE, BY REGION, 2023 VS 2030 (%)INHALED NITRIC OXIDE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)GLOBAL INHALED NITRIC OXIDE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  5. Market Insights
    1. Market DynamicsINHALED NITRIC OXIDE MARKET DYNAMICS
      1. Drivers
        1. Rising incidents of respiratory disorders worldwide
        2. Increase in neonatal intensive care facilities with growing healthcare expenditure
      2. Restraints
        1. High cost associated with treatments involving inhaled nitric oxide
      3. Opportunities
        1. Improvements in production and storage technologies of inhaled nitric oxide
        2. Continuous research to boost the application of inhaled nitric oxide
      4. Challenges
        1. Stringent government regulations for inhaled nitric oxide usage
    2. Market Segmentation Analysis
      1. Application: Increasing incidences of chronic obstructive pulmonary disease
      2. End-Users: Growing deployment of inhaled nitric oxide devices in hospitals for neonatal and intensive care units
    3. Market Trend Analysis
      1. Ongoing research activities and approval inhaled nitric oxide products in Americas
      2. Growing burden of respiratory disorders improving the adoption of inhaled nitric oxide in the Asia-Pacific
      3. Presence of key market players and stringent regulatory landscape for inhaled nitric oxide products across EMEA region
    4. Cumulative Impact of High Inflation
    5. Porter’s Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    6. Value Chain & Critical Path Analysis
    7. Regulatory Framework
  6. Inhaled Nitric Oxide Market, by Application
    1. IntroductionINHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
    2. Acute Respiratory Distress SyndromeINHALED NITRIC OXIDE MARKET SIZE, BY ACUTE RESPIRATORY DISTRESS SYNDROME, BY , 2018-2030 (USD MILLION)
    3. Chronic Obstructive Pulmonary DiseaseINHALED NITRIC OXIDE MARKET SIZE, BY CHRONIC OBSTRUCTIVE PULMONARY DISEASE, BY , 2018-2030 (USD MILLION)
    4. Malaria TreatmentINHALED NITRIC OXIDE MARKET SIZE, BY MALARIA TREATMENT, BY , 2018-2030 (USD MILLION)
    5. Neonatal Respiratory TreatmentINHALED NITRIC OXIDE MARKET SIZE, BY NEONATAL RESPIRATORY TREATMENT, BY , 2018-2030 (USD MILLION)
    6. Tuberculosis TreatmentINHALED NITRIC OXIDE MARKET SIZE, BY TUBERCULOSIS TREATMENT, BY , 2018-2030 (USD MILLION)
  7. Inhaled Nitric Oxide Market, by End-Users
    1. IntroductionINHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2023 VS 2030 (%)INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2023 VS 2024 VS 2030 (USD MILLION)INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    2. ClinicINHALED NITRIC OXIDE MARKET SIZE, BY CLINIC, BY , 2018-2030 (USD MILLION)
    3. HospitalINHALED NITRIC OXIDE MARKET SIZE, BY HOSPITAL, BY , 2018-2030 (USD MILLION)
  8. Americas Inhaled Nitric Oxide Market
    1. Introduction
    2. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    3. AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)AMERICAS INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Argentina
    5. ARGENTINA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)ARGENTINA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    6. Brazil
    7. BRAZIL INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)BRAZIL INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    8. Canada
    9. CANADA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)CANADA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    10. Mexico
    11. MEXICO INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)MEXICO INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    12. United States
    13. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    14. UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY STATE, 2023 VS 2030 (%)UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)UNITED STATES INHALED NITRIC OXIDE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  9. Asia-Pacific Inhaled Nitric Oxide Market
    1. Introduction
    2. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    3. ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)ASIA-PACIFIC INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Australia
    5. AUSTRALIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)AUSTRALIA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    6. China
    7. CHINA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)CHINA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    8. India
    9. INDIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)INDIA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    10. Indonesia
    11. INDONESIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)INDONESIA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    12. Japan
    13. JAPAN INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)JAPAN INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    14. Malaysia
    15. MALAYSIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)MALAYSIA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    16. Philippines
    17. PHILIPPINES INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)PHILIPPINES INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    18. Singapore
    19. SINGAPORE INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)SINGAPORE INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    20. South Korea
    21. SOUTH KOREA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)SOUTH KOREA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    22. Taiwan
    23. TAIWAN INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)TAIWAN INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    24. Thailand
    25. THAILAND INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)THAILAND INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    26. Vietnam
    27. VIETNAM INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)VIETNAM INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  10. Europe, Middle East & Africa Inhaled Nitric Oxide Market
    1. Introduction
    2. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    3. EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)EUROPE, MIDDLE EAST & AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
    4. Denmark
    5. DENMARK INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)DENMARK INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    6. Egypt
    7. EGYPT INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)EGYPT INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    8. Finland
    9. FINLAND INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)FINLAND INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    10. France
    11. FRANCE INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)FRANCE INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    12. Germany
    13. GERMANY INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)GERMANY INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    14. Israel
    15. ISRAEL INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)ISRAEL INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    16. Italy
    17. ITALY INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)ITALY INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    18. Netherlands
    19. NETHERLANDS INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)NETHERLANDS INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    20. Nigeria
    21. NIGERIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)NIGERIA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    22. Norway
    23. NORWAY INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)NORWAY INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    24. Poland
    25. POLAND INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)POLAND INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    26. Qatar
    27. QATAR INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)QATAR INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    28. Russia
    29. RUSSIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)RUSSIA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    30. Saudi Arabia
    31. SAUDI ARABIA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)SAUDI ARABIA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    32. South Africa
    33. SOUTH AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)SOUTH AFRICA INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    34. Spain
    35. SPAIN INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)SPAIN INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    36. Sweden
    37. SWEDEN INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)SWEDEN INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    38. Switzerland
    39. SWITZERLAND INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)SWITZERLAND INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    40. Turkey
    41. TURKEY INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)TURKEY INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    42. United Arab Emirates
    43. UNITED ARAB EMIRATES INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)UNITED ARAB EMIRATES INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
    44. United Kingdom
    45. UNITED KINGDOM INHALED NITRIC OXIDE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)UNITED KINGDOM INHALED NITRIC OXIDE MARKET SIZE, BY END-USERS, 2018-2030 (USD MILLION)
  11. Competitive Landscape
    1. FPNV Positioning MatrixINHALED NITRIC OXIDE MARKET, FPNV POSITIONING MATRIX, 2023INHALED NITRIC OXIDE MARKET, FPNV POSITIONING MATRIX, 2023
    2. Market Share Analysis, By Key PlayerINHALED NITRIC OXIDE MARKET SHARE, BY KEY PLAYER, 2023INHALED NITRIC OXIDE MARKET SHARE, BY KEY PLAYER, 2023
    3. Competitive Scenario Analysis, By Key Player
      1. Vero Biotech Secures USD 65 Million Credit Facility for Nitric Oxide Delivery System
      2. Third Pole Doses First Patient in Trial with Nitric Oxide Delivery System
      3. Mallinckrodt Announces FDA Clearance of the INOmax EVOLVE DS Delivery System and Approval of the INOmax (Nitric Oxide) Mini-Cylinder
      4. UAB Researchers Receive Grant to Develop Devices That Can Improve Quality of Life for Patients with Pulmonary Hypertension
      5. Beyond Air Secures up to USD 40 Million Debt Financing
      6. VERO Biotech Raises USD 30 Million to Accelerate Commercialization of Its Innovative Tankless Inhaled Nitric Oxide Delivery System
      7. VERO Biotech Receives FDA Approval of its Third Generation Tankless Inhaled Nitric Oxide Delivery System
      8. SaNOtize Announces USD 24 Million in Series B Funding to Advance It's Nitric Oxide-Based Therapeutics, Including Nasal Spray for the Treatment and Prevention of COVID-19
  12. Competitive Portfolio
    1. Key Company Profiles
      1. Air Liquide SA
      2. Beyond Air, Inc.
      3. GE HealthCare Technologies, Inc.
      4. Getinge AB
      5. Linde PLC
      6. Mallinckrodt PLC
      7. Matheson Tri-Gas, Inc. by Mitsubishi Chemical Group Corporation
      8. Merck KGaA
      9. NIOX Group PLC
      10. Perma Pure LLC by Halma PLC
      11. SOL Group
      12. Third Pole, Inc.
      13. VERO Biotech Inc.
    2. Key Product Portfolio
  1. Air Liquide SA
  2. Beyond Air, Inc.
  3. GE HealthCare Technologies, Inc.
  4. Getinge AB
  5. Linde PLC
  6. Mallinckrodt PLC
  7. Matheson Tri-Gas, Inc. by Mitsubishi Chemical Group Corporation
  8. Merck KGaA
  9. NIOX Group PLC
  10. Perma Pure LLC by Halma PLC
  11. SOL Group
  12. Third Pole, Inc.
  13. VERO Biotech Inc.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.
Frequently Asked Questions about the Inhaled Nitric Oxide Market
The Global Inhaled Nitric Oxide Market size was estimated at USD 778.21 million in 2023 and expected to reach USD 821.09 million in 2024.
The Global Inhaled Nitric Oxide Market to grow USD 1,157.38 million by 2030, at a CAGR of 5.83%
Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
We are approaching our 7th anniversary in 2024!
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
Absolutely yes, with the purchase of additional user licenses.
Absolutely yes, so long as the 360iResearch cited correctly.